Chong Kun Dang Pharmaceutical (185750)

Seoul
132,000.00
-2,000.00(-1.49%)
  • Volume:
    8,338
  • Bid/Ask:
    131,500.00/132,000.00
  • Day's Range:
    132,000.00 - 134,000.00

185750 Overview

Prev. Close
134,000
Day's Range
132,000 - 134,000
Revenue
1.3T
Open
133,000
52 wk Range
87,905 - 273,333
EPS
8,066.7
Volume
8,338
Market Cap
1.53T
Dividend (Yield)
952.38 (0.71%)
Average Vol. (3m)
60,339
P/E Ratio
16.61
Beta
1.34
1-Year Change
35.22%
Shares Outstanding
11,355,815
Next Earnings Date
May 11, 2021
What is your sentiment on Chong Kun Dang Pharmaceutical?
or
Vote to see community's results!

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuySellSellBuy
Technical IndicatorsBuyStrong BuySellStrong SellBuy
SummaryBuyStrong BuySellStrong SellBuy

Chong Kun Dang Pharmaceutical Company Profile

Chong Kun Dang Pharmaceutical Company Profile

Employees
1904

Chong Kun Dang Pharmaceutical Corp is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The company sells products in domestic and overseas markets.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.